BALYASNY ASSET MANAGEMENT L.P. - MEDTECH ACQUISITION CORP ownership

MEDTECH ACQUISITION CORP's ticker is MTACW and the CUSIP is 58507N113. A total of 29 filers reported holding MEDTECH ACQUISITION CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of MEDTECH ACQUISITION CORP
ValueSharesWeighting
Q1 2023$7,588
+58.9%
95,5100.0%0.00%
Q4 2022$4,776
-20.4%
95,5100.0%0.00%
Q3 2022$6,000
-25.0%
95,5100.0%0.00%
Q2 2022$8,000
-66.7%
95,5100.0%0.00%
Q1 2022$24,000
-52.0%
95,5100.0%0.00%
Q4 2021$50,000
-35.9%
95,5100.0%0.00%
Q3 2021$78,000
-17.9%
95,5100.0%0.00%
Q2 2021$95,000
-9.5%
95,5100.0%0.00%
-100.0%
Q1 2021$105,00095,5100.00%
Other shareholders
MEDTECH ACQUISITION CORP shareholders Q1 2023
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 500,000$4,900,0000.26%
ANGELO GORDON & CO., L.P. 95,808$939,0000.11%
CastleKnight Management LP 46,371$454,0000.06%
Radcliffe Capital Management, L.P. 138,194$1,354,0000.03%
Q Global Advisors, LLC 49,561$13,0000.01%
MYDA Advisors LLC 42,949$11,0000.00%
Magnetar Financial LLC 1,243,264$315,0000.00%
Kepos Capital LP 145,000$37,0000.00%
Bracebridge Capital, LLC 98,857$25,0000.00%
SPRING CREEK CAPITAL LLC 167,566$42,0000.00%
View complete list of MEDTECH ACQUISITION CORP shareholders